Sanghamitra Pati1, Shreeporna Bhattacharya2, Subhashisa Swain3. 1. Director and Scientist G, Department of Health Research Centre, ICMR-Regional Medical Research Centre, Bhubaneswar, Odisha, India. 2. Research Associate, Department of Public Health, Indian Institute of Public Health, Public Health Foundation of India, Bhubaneswar, Odisha, India. 3. Tutor, Department of Public Health, Indian Institute of Public Health, Public Health Foundation of India, Bhubaneswar, Odisha, India.
Abstract
INTRODUCTION: Improved and efficient Anti-Retroviral Therapy (ART) has turned HIV positive into a chronic disorder. The increase in life expectancy and quality of life comes with an increased risk of multimorbidity from the traditional risk factors. AIM: To explore the prevalence of multimorbidity among People Living with HIV (PLHIV). MATERIALS AND METHODS: An exploratory cross-sectional study was carried out in an ART center of Odisha, India, from November 2013 to December 2013. A systematic random sampling was done to include 197 adult HIV positive patients receiving ART at least for one year or more. A structured questionnaire was used to collect data on socio-demographic profile, ART status, multimorbidity and opportunistic infections. RESULTS: The prevalence of multimorbidity was 47.7% (95% CI 41% to 55%). Among them, the most common chronic conditions were pulmonary tuberculosis (28.4%), gastro-intestinal conditions (7.1%), neural disorders (5.1%) and hypertension (2.5%). In total, 48.7% had opportunistic infections; with 36% bacterial, 25% fungal and 21% viral infections. CONCLUSION: The prevalence of multimorbidity was high among HIV positive patients. Further research should explore the epidemiology of multimorbidity among HIV positive patients to formulate proper clinical practice guidelines to enhance long-term outcomes of PLHIV in the current treatment era.
INTRODUCTION: Improved and efficient Anti-Retroviral Therapy (ART) has turned HIV positive into a chronic disorder. The increase in life expectancy and quality of life comes with an increased risk of multimorbidity from the traditional risk factors. AIM: To explore the prevalence of multimorbidity among People Living with HIV (PLHIV). MATERIALS AND METHODS: An exploratory cross-sectional study was carried out in an ART center of Odisha, India, from November 2013 to December 2013. A systematic random sampling was done to include 197 adult HIV positive patients receiving ART at least for one year or more. A structured questionnaire was used to collect data on socio-demographic profile, ART status, multimorbidity and opportunistic infections. RESULTS: The prevalence of multimorbidity was 47.7% (95% CI 41% to 55%). Among them, the most common chronic conditions were pulmonary tuberculosis (28.4%), gastro-intestinal conditions (7.1%), neural disorders (5.1%) and hypertension (2.5%). In total, 48.7% had opportunistic infections; with 36% bacterial, 25% fungal and 21% viral infections. CONCLUSION: The prevalence of multimorbidity was high among HIV positive patients. Further research should explore the epidemiology of multimorbidity among HIV positive patients to formulate proper clinical practice guidelines to enhance long-term outcomes of PLHIV in the current treatment era.
Authors: S U Munshi; M M Hoque; Mea Mondol; M Jalaluddin; S Tabassum; M N Islam Journal: Indian J Med Microbiol Date: 2008 Jul-Sep Impact factor: 0.985
Authors: N Kumarasamy; Snigdha Vallabhaneni; Timothy P Flanigan; Kenneth H Mayer; Suniti Solomon Journal: Indian J Med Res Date: 2005-04 Impact factor: 2.375
Authors: Rosie Mayston; Vikram Patel; Melanie Abas; Priya Korgaonkar; Ramesh Paranjape; Savio Rodrigues; Martin Prince Journal: Trop Med Int Health Date: 2014-12-22 Impact factor: 2.622
Authors: Joseph L Goulet; Shawn L Fultz; David Rimland; Adeel Butt; Cynthia Gibert; Maria Rodriguez-Barradas; Kendall Bryant; Amy C Justice Journal: Clin Infect Dis Date: 2007-12-15 Impact factor: 9.079
Authors: Karen Barnett; Stewart W Mercer; Michael Norbury; Graham Watt; Sally Wyke; Bruce Guthrie Journal: Lancet Date: 2012-05-10 Impact factor: 79.321
Authors: V G Rao; J Bhat; R Yadav; M Muniyandi; M K Bhondeley; M A Sharada; V K Chadha; D F Wares Journal: Trans R Soc Trop Med Hyg Date: 2014-06-26 Impact factor: 2.184
Authors: Claire E Kendall; Jenna Wong; Monica Taljaard; Richard H Glazier; William Hogg; Jaime Younger; Douglas G Manuel Journal: BMC Public Health Date: 2014-02-13 Impact factor: 3.295